Clinical trial
mRNA Expression and Genetic Polymorphisms Affecting DRD3 (rs6280) and HTR2A (rs6313) in Bruxism
NCT06457646 is registered in ClinicalTrials.gov with University of Monastir as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- mRNA Expression and Genetic Polymorphisms Affecting DRD3 (rs6280) and HTR2A (rs6313) in Bruxism
- Lead sponsor
- University of Monastir
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- June 2, 2024
- Completion date
- December 17, 2024
- Enrollment
- 169 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.